Search Results - Michael Sebag

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus by Donna Reece, C. Tom Kouroukis, Richard LeBlanc, Michael Sebag, Kevin Song, John Ashkenas

    Published in Advances in Hematology (2012-01-01)
    Get full text
    Article


  2. 2

    Perspectives on Outpatient Delivery of Bispecific T-Cell Engager Therapies for Multiple Myeloma by Andrée-Anne Pelland, Mathilde Dumas, Émilie Lemieux-Blanchard, Richard LeBlanc, Julie Côté, Jean-Samuel Boudreault, Dominic Duquette, Rayan Kaedbey, Marc Lalancette, Frédéric Larose, Anna Nikonova, Michel Pavic, April Shamy, Jean Roy, Michael Sebag, Sabrina Trudel, Jean-Sébastien Claveau

    Published in Current Oncology (2025-04-01)
    Get full text
    Article


  3. 3

    P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF... by Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous, Jesus Berdeja, Jesse Shustik, Gary Schiller, Siddhartha Ganguly, Kevin Song, Christopher S. Seet, Mirelis Acosta-Rivera, Donald Quick, Bertrand Anz, Gustavo Fonseca, Unicel-Anne Flores, Hongjuan Liu, Christian Gentili, David Siegel

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database by Arleigh McCurdy, Christopher P. Venner, Esther Masih-Khan, Martha Louzada, Richard LeBlanc, Michael Sebag, Kevin Song, Victor H. Jimenez-Zepeda, Rami Kotb, Moustafa Kardjadj, Hira Mian, Darrell White, Julie Stakiw, Muhammad Aslam, Anthony Reiman, Engin Gul, Donna Reece

    Published in Current Oncology (2022-03-01)
    Get full text
    Article


  5. 5

    Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database by Hira Mian, Richard LeBlanc, Martha Louzada, Esther Masih‐Khan, Arleigh McCurdy, Christopher P. Venner, Julie Stakiw, Moustafa Kardjadj, Victor H. Jimenez‐Zepeda, Michael Sebag, Darrell White, Muhammad Aslam, Kevin Song, Anthony Reiman, Rami Kotb, Engin Gul, Donna Reece

    Published in Cancer Medicine (2023-02-01)
    Get full text
    Article


  6. 6

    Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database by Arleigh McCurdy, Martha Louzada, Christopher P. Venner, Alissa Visram, Esther Masih‐Khan, Moustafa Kardjadj, Victor H. Jimenez‐Zepeda, Richard LeBlanc, Michael Sebag, Kevin Song, Darrell White, Hira Mian, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Rami Kotb, Engin Gul, Donna Reece

    Published in eJHaem (2022-11-01)
    Get full text
    Article


  7. 7

    Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional repo... by Rayan Kaedbey, Donna Reece, Christopher P. Venner, Arleigh McCurdy, Jiandong Su, Michael Chu, Martha Louzada, Victor H Jimenez‐Zepeda, Hira Mian, Kevin Song, Michael Sebag, Julie Stakiw, Darrell White, Anthony Reiman, Muhammad Aslam, Rami Kotb, Debra Bergstrom, Engin Gul, Richard LeBlanc

    Published in eJHaem (2024-06-01)
    Get full text
    Article


  8. 8

    The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database by Hannah M. Cherniawsky, Vishal Kukreti, Donna Reece, Esther Masih-Khan, Arleigh McCurdy, Victor H. Jimenez-Zepeda, Michael Sebag, Kevin Song, Darrell White, Julie Stakiw, Richard LeBlanc, Anthony Reiman, Muhammad Aslam, Martha Louzada, Rami Kotb, Engin Gul, Eshetu Atenafu, Christopher P. Venner

    Published in Haematologica (2020-10-01)
    Get full text
    Article


  9. 9

    S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIP... by Maria-Victoria Mateos, Daniel Morillo, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Albert Oriol, Enrique Ocio, Sung-Soo Yoon, Yael Cohen, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Yue Guo, Maria Krevvata, Michelle Peterson, Melissa Beelen, Jill Vanak, Arnob Banerjee, Hila Magen

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  10. 10

    Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis by Arleigh McCurdy, Hira Mian, Richard LeBlanc, Victor H. Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White, Michael Sebag, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rami Kotb, Rayan Kaedbey, Engin Gul, Donna Reece, Christopher P. Venner

    Published in Blood Cancer Journal (2023-07-01)
    Get full text
    Article


  11. 11

    Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis by Arleigh McCurdy, Hira Mian, Richard LeBlanc, Victor H. Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White, Michael Sebag, Julie Stakiw, Anthony Reiman, Muhammad Aslam, Debra Bergstrom, Rami Kotb, Rayan Kaedbey, Engin Gul, Donna Reece, Christopher P. Venner

    Published in Blood Cancer Journal (2023-08-01)
    Get full text
    Article


  12. 12

    Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study by Mégane Tanguay, Jean Roy, Jiandong Su, Engin Gul, Donna Reece, Christopher P. Venner, Darrell White, Michael P. Chu, Victor H. Jimenez‐Zepada, Kevin Song, Arleigh Mccurdy, Hira Mian, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Rayan Kaedbey, Martha Louzada, Richard LeBlanc

    Published in Cancer Medicine (2024-11-01)
    Get full text
    Article


  13. 13

    Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database by Julie Côté, Richard LeBlanc, Hira Mian, Michael P. Chu, Arleigh McCurdy, Esther Masih-Khan, Jiandong Su, Victor H. Jimenez-Zepeda, Kevin Song, Martha Louzada, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P. Venner, Engin Gul, Donna Reece

    Published in Blood Cancer Journal (2023-09-01)
    Get full text
    Article


  14. 14

    Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma by Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, Natalie Callander, Sascha Tuchman, Christine Chen, Darrell White, Rami Kotb, Heather Sutherland, Michael Sebag, Muhamed Baljevic, William Bensinger, Richard LeBlanc, Chris Venner, Nizar Bahlis, Adriana Rossi, Noa Biran, Heidi Sheehan, Jean‐Richard Saint‐Martin, Dane Van Domelen, Kazuharu Kai, Jatin Shah, Sharon Shacham, Michael Kauffman, Brea Lipe

    Published in eJHaem (2021-02-01)
    Get full text
    Article


  15. 15

    Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment by Muhamed Baljevic, Cristina Gasparetto, Gary J. Schiller, Sascha A. Tuchman, Natalie S. Callander, Suzanne Lentzsch, Jorge Monge, Rami Kotb, Nizar J. Bahlis, Darrell White, Christine I. Chen, Heather J. Sutherland, Sumit Madan, Richard LeBlanc, Michael Sebag, Christopher P. Venner, William I. Bensinger, Noa Biran, Andrew DeCastro, Dane R. Van Domelen, Chris Zhang, Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Ohad S. Bentur, Brea Lipe

    Published in eJHaem (2022-11-01)
    Get full text
    Article


Search Tools: